St. Louis encephalitis medical therapy: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{St. Louis encephalitis}} | {{St. Louis encephalitis}} | ||
{{CMG}}; {{AE}} {{AG}}; '''Contributor(s):''' {{VVS}} | {{CMG}}; {{AE}} {{AG}}; '''Contributor(s):''' {{VVS}}, {{Irfan Dotani}} | ||
{{ | |||
==Overview== | ==Overview== | ||
Revision as of 11:37, 1 August 2016
|
St. Louis encephalitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
St. Louis encephalitis medical therapy On the Web |
|
American Roentgen Ray Society Images of St. Louis encephalitis medical therapy |
|
Risk calculators and risk factors for St. Louis encephalitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anthony Gallo, B.S. [2]; Contributor(s): Vishnu Vardhan Serla M.B.B.S. [3], Irfan Dotani [4]
Overview
No vaccine against SLEV infection or specific antiviral treatment for clinical SLEV infections is available. Patients with suspected SLE should be evaluated by a healthcare provider, appropriate serologic and other diagnostic tests ordered, and supportive treatment provided.
There are no vaccines or any other treatments specifically for Saint Louis encephalitis virus, although one study showed that early use of interferon-alpha2b may decrease the severity of complications.[1]
Medical Therapy
References
- ↑ Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis. 2004;15;190(6):1084-7.